Jiang, K.
Cao, F.
Yin, L.
Hu, Y.
Zhao, X.
Huang, X.
Ma, X.
Li, J.
Lu, M.
Funding for this research was provided by:
Beijing Natural Science Foundation (7232018, Z200015)
National Natural Foundation of China (92259302)
the Rare Tumor Research Special Project of the National Natural Science Foundation of China (82141104)
Article History
Received: 21 August 2023
Accepted: 9 November 2023
First Online: 7 December 2023
Declarations
:
: The authors have no conflicts of interest to declare.
: Human samples and clinical data were collected and used in accordance with the principles of the Declaration of Helsinki and approved by the Ethics committee of Peking University Cancer Hospital.
: All participants provided written informed consents, approval number 2023KT98.